mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
3e-15 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
9e-15 |
mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
0.3 |
5e-14 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
3e-13 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
3e-12 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
6e-12 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
6e-11 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
3e-10 |
mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
7e-10 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
1e-09 |